Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
543 | 13957 | 45.1 | 92% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
18 | 119602 | JOURNAL OF IMMUNOLOGY//IMMUNOL//DENDRITIC CELLS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
753 | 3021 | IL 17//INTERLEUKIN 17//TH17 |
4109 | 1769 | MOL TUMOR BIOL//CELLULAR GENE THER IES//IL 13 RECEPTOR |
4905 | 1635 | INTERLEUKIN 18//IL 18//INTERLEUKIN 18 BINDING PROTEIN |
5560 | 1541 | INTERLEUKIN 12//IL 12//IL 12 RECEPTOR |
8442 | 1184 | IL 33//INTERLEUKIN 33//ST2 |
8801 | 1147 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
9609 | 1071 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
11439 | 915 | IL 24//MDA 7//IL 22 |
17153 | 551 | IL 27//INTERLEUKIN 27//IL 35 |
20687 | 389 | THYMIC STROMAL LYMPHOPOIETIN//TSLP//THYMIC STROMAL LYMPHOPOIETIN TSLP |
22233 | 332 | IL 9//INTERLEUKIN 9//MAGAININ MOL MED |
25898 | 222 | IL 37//TIR8//INTERLEUKIN 37 |
27862 | 180 | INTERLEUKIN 32//IL 32//CYTOKINE IMMUNOL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERLEUKIN 18 | Author keyword | 321 | 52% | 3% | 439 |
2 | IL 18 | Author keyword | 231 | 48% | 3% | 353 |
3 | IL 17 | Author keyword | 221 | 40% | 3% | 434 |
4 | IL 33 | Author keyword | 219 | 70% | 1% | 180 |
5 | INTERLEUKIN 33 | Author keyword | 184 | 79% | 1% | 116 |
6 | INTERLEUKIN 17 | Author keyword | 171 | 45% | 2% | 288 |
7 | ST2 | Author keyword | 147 | 74% | 1% | 109 |
8 | IL 22 | Author keyword | 142 | 61% | 1% | 149 |
9 | IL 27 | Author keyword | 127 | 74% | 1% | 95 |
10 | INTERLEUKIN 12 | Author keyword | 121 | 28% | 3% | 367 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERLEUKIN 18 | 321 | 52% | 3% | 439 | Search INTERLEUKIN+18 | Search INTERLEUKIN+18 |
2 | IL 18 | 231 | 48% | 3% | 353 | Search IL+18 | Search IL+18 |
3 | IL 17 | 221 | 40% | 3% | 434 | Search IL+17 | Search IL+17 |
4 | IL 33 | 219 | 70% | 1% | 180 | Search IL+33 | Search IL+33 |
5 | INTERLEUKIN 33 | 184 | 79% | 1% | 116 | Search INTERLEUKIN+33 | Search INTERLEUKIN+33 |
6 | INTERLEUKIN 17 | 171 | 45% | 2% | 288 | Search INTERLEUKIN+17 | Search INTERLEUKIN+17 |
7 | ST2 | 147 | 74% | 1% | 109 | Search ST2 | Search ST2 |
8 | IL 22 | 142 | 61% | 1% | 149 | Search IL+22 | Search IL+22 |
9 | IL 27 | 127 | 74% | 1% | 95 | Search IL+27 | Search IL+27 |
10 | INTERLEUKIN 12 | 121 | 28% | 3% | 367 | Search INTERLEUKIN+12 | Search INTERLEUKIN+12 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TH17 CELLS | 449 | 38% | 7% | 935 |
2 | ROR GAMMA T | 399 | 53% | 4% | 527 |
3 | GAMMA INDUCING FACTOR | 370 | 61% | 3% | 393 |
4 | IL 17 | 367 | 49% | 4% | 550 |
5 | INTERLEUKIN 17 | 319 | 46% | 4% | 522 |
6 | CYTOKINE | 309 | 17% | 12% | 1646 |
7 | IL 18 | 294 | 51% | 3% | 412 |
8 | AUTOIMMUNE INFLAMMATION | 245 | 53% | 2% | 329 |
9 | LYMPHOCYTE MATURATION FACTOR | 244 | 70% | 1% | 201 |
10 | CELL STIMULATORY FACTOR | 219 | 51% | 2% | 305 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The biology of innate lymphoid cells | 2015 | 14 | 117 | 79% |
IL-17 and Th17 Cells | 2009 | 1594 | 221 | 66% |
Interleukin-17 family members and inflammation | 2004 | 1096 | 76 | 86% |
Interleukin-12 and the regulation of innate resistance and adaptive immunity | 2003 | 1924 | 136 | 68% |
Innate lymphoid cells - how did we miss them? | 2013 | 170 | 104 | 64% |
Therapeutic opportunities of the IL-22-IL-22R1 system | 2014 | 48 | 167 | 84% |
Lung ILC2s link innate and adaptive responses in allergic inflammation | 2015 | 6 | 59 | 81% |
The immunology of asthma | 2015 | 14 | 176 | 34% |
IL-17 family cytokines and the expanding diversity of effector T cell lineages | 2007 | 994 | 127 | 77% |
Functional Specialization of Interleukin-17 Family Members | 2011 | 275 | 137 | 77% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL TUMOR BIOL | 53 | 52% | 0.5% | 72 |
2 | CELLULAR GENE THER IES | 41 | 33% | 0.7% | 101 |
3 | IMMUNOL MED ZOOL | 30 | 38% | 0.4% | 62 |
4 | EXPT MED UNIT | 29 | 35% | 0.5% | 66 |
5 | FUJISAKI | 23 | 38% | 0.3% | 48 |
6 | BIOL EVALUAT NIH | 23 | 100% | 0.1% | 10 |
7 | EXPT PATHOL PHARMACOL | 21 | 71% | 0.1% | 17 |
8 | CYTOKINE IMMUNOL | 21 | 61% | 0.2% | 22 |
9 | MAGAININ MOL MED | 18 | 89% | 0.1% | 8 |
10 | TUMOR VACCINES BIOTECHNOL BRANCH | 18 | 49% | 0.2% | 26 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015775 | INTERLEUKIN 10//IL 1RN//INTERLEUKIN 1 BETA GENE |
2 | 0.0000015745 | FOXP3//CTLA 4//REGULATORY T CELLS |
3 | 0.0000015070 | STAT3//INTERLEUKIN 7//SOCS |
4 | 0.0000010910 | ORAL TOLERANCE//DC SIGN//DENDRITIC CELLS |
5 | 0.0000010663 | COLLAGEN INDUCED ARTHRITIS//SECT MED INFLAMMAT//INTERLEUKIN 1 RECEPTOR ANTAGONIST |
6 | 0.0000008404 | INFLAMMASOME//C REACTIVE PROTEIN//NLRP3 |
7 | 0.0000008316 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY |
8 | 0.0000007547 | CD1D//GAMMA DELTA T CELLS//ALPHA GALACTOSYLCERAMIDE |
9 | 0.0000007333 | CD40//BAFF//CD40 LIGAND |
10 | 0.0000007040 | MASTOCYTOSIS//MAST CELLS//MAST CELL |